LAS VEGAS — The PanOptix trifocal IOL provided good visual outcomes at 1-month, according to research presented at the American Society of Cataract and Refractive Surgery meeting.
Jerry G. Hu, MD, from Texas Eye and Laser Center said the study was originally intended to be presented at ASCRS 2020 but got delayed by the COVID-19 pandemic.
“By now, most of us have had first-hand experience with this implant,” he said. “It’s no longer quite timely, but it’s still good, qualitative work, and the findings are still clinically relevant.”
Researchers obtained

LAS VEGAS — The PanOptix trifocal IOL provided good visual outcomes at 1-month, according to research presented at the American Society of Cataract and Refractive Surgery meeting.
Jerry G. Hu, MD, from Texas Eye and Laser Center said the study was originally intended to be presented at ASCRS 2020 but got delayed by the COVID-19 pandemic.
“By now, most of us have had first-hand experience with this implant,” he said. “It’s no longer quite timely, but it’s still good, qualitative work, and the findings are still clinically relevant.”
Researchers obtained